KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Jazz Pharmaceuticals (JAZZ) over the last 17 years, with Q3 2025 value amounting to 0.29.

  • Jazz Pharmaceuticals' Asset Utilization Ratio fell 1352.97% to 0.29 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.29, marking a year-over-year decrease of 1352.97%. This contributed to the annual value of 0.35 for FY2024, which is 78.58% up from last year.
  • Jazz Pharmaceuticals' Asset Utilization Ratio amounted to 0.29 in Q3 2025, which was down 1352.97% from 0.28 recorded in Q2 2025.
  • Jazz Pharmaceuticals' Asset Utilization Ratio's 5-year high stood at 0.37 during Q1 2021, with a 5-year trough of 0.22 in Q3 2021.
  • Over the past 5 years, Jazz Pharmaceuticals' median Asset Utilization Ratio value was 0.34 (recorded in 2024), while the average stood at 0.31.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first crashed by 3958.97% in 2021, then skyrocketed by 4899.66% in 2022.
  • Over the past 5 years, Jazz Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.25 in 2021, then soared by 38.09% to 0.34 in 2022, then fell by 1.61% to 0.34 in 2023, then dropped by 1.18% to 0.34 in 2024, then decreased by 12.81% to 0.29 in 2025.
  • Its Asset Utilization Ratio was 0.29 in Q3 2025, compared to 0.28 in Q2 2025 and 0.27 in Q1 2025.